Medicare Enrolled

Dr. Freddy Espinoza, FNP

Physician Assistant · Fresno, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7085 N CHESTNUT AVE STE 101, Fresno, CA 93720
5593239236
In practice since 2014 (12 years)
NPI: 1124440524 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Espinoza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Espinoza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Espinoza

Dr. Freddy Espinoza is a physician assistant in Fresno, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Espinoza performed 350 Medicare services across 173 unique beneficiaries.

Between the years covered by Open Payments, Dr. Espinoza received a total of $26,623 from 53 pharmaceutical and/or device companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Espinoza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 32% volume in CA $26,623 industry payments

Medicare Practice Summary

Medicare Utilization ↗
350
Medicare services
Top 32% in CA for physician assistant
173
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
181 $88 $325
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
89 $24 $88
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
40 $109 $429
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $59 $230
Hemoglobin a1c level, by device for home use 19 $10 $24
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$26,623
Total received (2021-2024)
Avg $6,656/year across 4 years
Top 1% in CA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
685
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,477 (69.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,367 (27.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$778 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,095
2023
$7,135
2022
$9,885
2021
$4,508

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$938
Lilly USA, LLC
$840
Amgen Inc.
$792
Bayer Healthcare Pharmaceuticals Inc.
$344
Abbott Laboratories
$329
Boehringer Ingelheim Pharmaceuticals, Inc.
$233
Xeris Pharmaceuticals, Inc.
$231
Esperion Therapeutics, Inc.
$155
Antares Pharma, Inc.
$149
Alexion Pharmaceuticals, Inc.
$144
Dexcom, Inc.
$134
SANOFI-AVENTIS U.S. LLC
$96
Ascensia Diabetes Care Us Inc.
$94
Ultragenyx Pharmaceutical Inc.
$84
RECORDATI_RARE_DISEASES_INC.
$82
ABBVIE INC.
$77
Verity Pharmaceuticals Inc.
$65
Medtronic, Inc.
$55
Radius Health, Inc.
$47
Ascendis Pharma Inc
$47
AstraZeneca Pharmaceuticals LP
$44
PFIZER INC.
$29
Acella Pharmaceuticals, LLC
$25
Averitas Pharma Inc.
$22
Neurocrine Biosciences, Inc.
$21
Tandem Diabetes Care, Inc.
$16
Top 3 companies account for 50.5% of 2024 payments
All-time payments by company (2021-2024) ›
Medtronic, Inc.
$7,947
Novo Nordisk Inc
$2,330
Lilly USA, LLC
$2,132
Amgen Inc.
$1,354
Abbott Laboratories
$1,100
Alexion Pharmaceuticals, Inc.
$1,064
Boehringer Ingelheim Pharmaceuticals, Inc.
$961
AstraZeneca Pharmaceuticals LP
$888
SANOFI-AVENTIS U.S. LLC
$759
Tandem Diabetes Care, Inc.
$576
Antares Pharma, Inc.
$539
Dexcom, Inc.
$536
Corcept Therapeutics
$507
Xeris Pharmaceuticals, Inc.
$502
Ultragenyx Pharmaceutical Inc.
$490
ABBVIE INC.
$435
MannKind Corporation
$367
Horizon Therapeutics plc
$360
Bayer Healthcare Pharmaceuticals Inc.
$344
Bayer HealthCare Pharmaceuticals Inc.
$341
Esperion Therapeutics, Inc.
$296
Insulet Corporation
$295
Nevro Corp.
$195
Radius Health, Inc.
$193
Supernus Pharmaceuticals, Inc.
$172
RECORDATI_RARE_DISEASES_INC.
$138
Teva Pharmaceuticals USA, Inc.
$125
GRT US Holding, Inc.
$125
MAYNE PHARMA COMMERCIAL LLC
$122
Organogenesis Inc.
$120
Amryt Pharma Holdings Ltd
$117
IBSA Pharma Inc.
$112
GlaxoSmithKline, LLC.
$112
Incyte Corporation
$100
PFIZER INC.
$97
Ascensia Diabetes Care Us Inc.
$94
AbbVie Inc.
$80
Ascendis Pharma Inc
$73
VIVUS LLC
$71
Ipsen Biopharmaceuticals, Inc
$67
Verity Pharmaceuticals Inc.
$65
Becton, Dickinson and Company
$64
Mannkind Corporation
$48
DEXCOM, INC.
$29
Bigfoot Biomedical Inc
$26
Acella Pharmaceuticals, LLC
$25
Averitas Pharma Inc.
$22
Neurocrine Biosciences, Inc.
$21
Kyowa Kirin, Inc.
$20
LifeScan, Inc.
$19
CeQur Corporation
$18
Ascensia Diabetes Care US Inc.
$16
Amarin Pharma Inc.
$13
Top 3 companies account for 46.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · InPen · JARDIANCE · JUXTAPID · Kerendia · Korlym · LICART · LYUMJEV · MINIMED 630G · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NEXLETOL · NEXLIZET · NEXTSTELLIS · NOCDURNA · NP Thyroid 60 · OPZELURA · Omnia · Omnipod · OneTouch Verio Reflect · Ozempic · Prolia · Puraply · QSYMIA · QULIPTA · QUTENZA · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · SYNTHROID · Senza · Sogroya · Strensiq · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · UZEDY · VRAYLAR · Vascepa · Wegovy · XYOSTED · ZEPBOUND · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for physician assistant in CA.

Looking for a physician assistant in Fresno?
Compare physician assistants in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
259
Per 100K population
25.6
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Espinoza is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 1% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Espinoza experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Espinoza performed 181 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Espinoza receive payments from pharmaceutical companies?
Yes. Dr. Espinoza received a total of $26,623 from 53 companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Espinoza's costs compare to other physician assistants in Fresno?
Dr. Espinoza's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Espinoza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →